Abbreviations ACS: acute coronary syndrome CV: cardiovascular GLP-1RA: glucagon-like peptide-1 receptor agonist DPP-4: dipeptidyl peptidase-4 HF: heart failure MACE: major adverse CV event SGLT2: sodium-glucose cotransporter 2 T2D: type 2 diabetes References Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ, et al
These medications not only help to improve glycemic control but also have been shown to have cardiovascular benefits in some patients
Grab your copy of the 7-Day GLP-1 Meal Plan and start fueling your body with meals that work with your appetite, not against it
35% of users reported no side effects
In the SURPASS clinical trial program for type 2 diabetes (Mounjaro), constipation was reported in approximately 12-17% of patients across the 5 mg, 10 mg, and 15 mg weekly doses, with higher rates generally observed at higher doses